Literature DB >> 1750648

A comparison of five devices for the bedside monitoring of heparin therapy.

A I O'Neill1, C McAllister, C F Corke, J D Parkin.   

Abstract

Five instruments were tested for their capacity to monitor heparin therapy on whole blood at the bedside. The instruments were 512 Coagulation Monitor (Ciba-Corning), Thrombotrack (Nycomed), Automated Coagulation Timer (Hemotec), Hemochron-ACT and Hemochron-APTT (International Technidyne Corporation). Fifty subjects with various levels of heparinisation were tested on each instrument and were also assayed for antithrombin III, fibrinogen, haematocrit, platelet count and plasma heparin level. The results were compared with a reference APTT performed on the Automated Coagulation Laboratory 300R (Instrumentation Laboratories). The Hemochron-ACT correlated least well. The Hemotec and Thrombotrack were unsuitable in a clinical setting because of pipetting requirements, although the Thrombotrack did correlate well with the reference parameters. The 512 Coagulation Monitor was the simplest to use, but its maximum response corresponded to the midpoint of the reference APTT therapeutic range. The Hemochron-APTT was simple to use, had an adequate response range and correlated well with reference parameters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750648     DOI: 10.1177/0310057X9101900423

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  3 in total

Review 1.  The role of point-of-care anticoagulation monitoring in arterial and venous thromboembolic disorders.

Authors:  C R Zimmerman
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

2.  The use of the activated clotting time for monitoring heparin therapy in critically ill patients.

Authors:  Jan J De Waele; Sebastiaan Van Cauwenberghe; Eric Hoste; Dominique Benoit; Francis Colardyn
Journal:  Intensive Care Med       Date:  2003-01-16       Impact factor: 17.440

3.  An ex vivo comparison of partial thromboplastin time and activated clotting time for heparin anticoagulation in an ovine model.

Authors:  Zachary B K Berk; Aakash Shah; Wenji Sun; Bartley P Griffith; Zhongjun J Wu
Journal:  Artif Organs       Date:  2021-11-02       Impact factor: 3.094

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.